FDA Inspection 1268309 — BioMarin Pharmaceutical, Inc.
The FDA completed an inspection of BioMarin Pharmaceutical, Inc. on March 26, 2025 in Novato, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 26, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Novato, CA (United States)